Feasibility of apalutamide combined with androgen deprivation therapy and short-course low-dose prednisone in treating metastatic hormone-sensitive prostate cancer: a pilot randomized controlled trial
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Feasibility of apalutamide combined with androgen deprivation therapy and short-course low-dose prednisone in treating metastatic hormone-sensitive prostate cancer: a pilot randomized controlled trial
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2023-11-06
DOI
10.3389/fonc.2023.1110807
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021
- (2022) Silke Gillessen et al. EUROPEAN UROLOGY
- Effects of apalutamide dose reduction on skin‐related adverse events in patients with advanced prostate cancer: A multicenter retrospective study
- (2022) Takuya Oishi et al. PROSTATE
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- NCCN Guidelines Insights: Prostate Cancer, Version 1.2021
- (2021) Edward Schaeffer et al. Journal of the National Comprehensive Cancer Network
- Apalutamide for patients with metastatic castrationsensitive prostate cancer in East Asia: a subgroup analysis of the TITAN trial
- (2021) Ding-Wei Ye et al. ASIAN JOURNAL OF ANDROLOGY
- EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer
- (2020) Philip Cornford et al. EUROPEAN UROLOGY
- Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II
- (2020) William T. Lowrance et al. JOURNAL OF UROLOGY
- Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
- (2019) Kim N. Chi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enzalutamide and Apalutamide: In Vitro Chemical Reactivity Studies and Activity in a Mouse Drug Allergy Model
- (2019) Changhua Ji et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Palatability of a novel oral formulation of prednisone in healthy young adults
- (2017) Shasha Bai et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial
- (2017) Hope S Rugo et al. LANCET ONCOLOGY
- Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
- (2017) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- New dimension of glucocorticoids in cancer treatment
- (2016) Kai-Ti Lin et al. STEROIDS
- Pemetrexed-Induced Rash May Be Prevented by Supplementary Corticosteroids
- (2015) Takumi Sakurada et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
- (2015) Christopher J. Sweeney et al. NEW ENGLAND JOURNAL OF MEDICINE
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer
- (2014) Atsushi Tomioka et al. BMC Urology
- ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
- (2012) N. J. Clegg et al. CANCER RESEARCH
- Nadir PSA level and time to PSA nadir following primary androgen deprivation therapy are the early survival predictors for prostate cancer patients with bone metastasis
- (2011) T Sasaki et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
- (2009) Qianben Wang et al. CELL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started